|
Delayed
Australian S.E.
04:29:10 06/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.0100 AUD | 0.00% |
|
+5.26% | -33.33% |
| 26/08 | Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 25/08 | Acrux Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 58.97L 41.1L 36.66L 34.16L 31.08L 58.53L 40Cr 4.13Cr 1.61Cr 20Cr 1.54Cr 1.51Cr 65Cr | P/E 2025 |
-0.95x | P/E 2026 | -8.4x |
|---|---|---|---|---|---|
| Enterprise Value | 67.1L 46.76L 41.72L 38.86L 35.37L 66.6L 45Cr 4.7Cr 1.83Cr 23Cr 1.76Cr 1.72Cr 74Cr | EV / Sales 2025 |
2.07x | EV / Sales 2026 | 1.08x |
| Free-Float |
95.6% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ACR | Delayed | |
OTC Markets
| ARUX.F | Delayed | |
Deutsche Boerse AG
| FJY | Delayed |
Last Transcript: Acrux Limited
| 23/22/23 | Acrux : Application for quotation of securities - ACR | PU |
| 14/22/14 | Acrux : Application for quotation of securities - ACR | PU |
| 16/22/16 | Acrux : Application for quotation of securities - ACR | PU |
| 25/22/25 | Acrux : Updated Board Charter | PU |
| 25/22/25 | Acrux : Application for quotation of securities - ACR | PU |
| 1 week | +5.26% | ||
| Current month | +11.11% | ||
| 1 month | -9.09% | ||
| 3 months | -16.67% | ||
| 6 months | -9.09% | ||
| Current year | -33.33% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0.01 | 0.02 | |
| 1 year | 0.01 | 0.02 | |
| 3 years | 0.01 | 0.1 | |
| 5 years | 0.01 | 0.13 | |
| 10 years | 0.01 | 0.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Warmbrunn
CEO | Chief Executive Officer | - | 01/06/2025 |
Joanna Johnson
DFI | Director of Finance/CFO | - | 21/06/2021 |
Jolanta Airey
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Dobinson
CHM | Chairman | 74 | 01/01/2006 |
Timothy Oldham
BRD | Director/Board Member | - | 01/10/2013 |
Geoff Brooke
BRD | Director/Board Member | 70 | 01/06/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +5.26% | -33.33% | -75.61% | 40.98L | ||
| +0.02% | -3.52% | +36.11% | +111.11% | 1,01900Cr | ||
| -1.21% | -6.99% | +34.08% | +60.96% | 62TCr | ||
| +1.12% | -0.20% | +13.62% | +80.24% | 46TCr | ||
| -3.30% | -6.15% | +56.45% | +34.69% | 36TCr | ||
| +0.93% | -1.83% | +21.65% | +41.43% | 33TCr | ||
| +0.12% | -4.05% | +10.70% | +33.53% | 27TCr | ||
| -0.89% | -5.83% | -7.00% | +7.91% | 24TCr | ||
| -0.01% | -3.62% | +35.28% | +52.02% | 22TCr | ||
| -0.08% | -4.98% | +28.34% | +93.61% | 18TCr | ||
| Average | +0.19% | -2.26% | +19.59% | +43.99% | 36.97TCr | |
| Weighted average by Cap. | +0.44% | -3.63% | +28.50% | +68.49% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 44.88L 31.28L 27.9L 26L 23.66L 44.55L 30Cr 3.14Cr 1.22Cr 15Cr 1.17Cr 1.15Cr 49Cr | 65.81L 45.86L 40.92L 38.12L 34.69L 65.33L 44Cr 4.61Cr 1.79Cr 23Cr 1.72Cr 1.68Cr 72Cr |
| Net income | -59.45L -41.43L -36.96L -34.43L -31.34L -59.01L -40Cr -4.16Cr -1.62Cr -20Cr -1.56Cr -1.52Cr -65Cr | -6L -4L -4L -3L -3L -6L -4.05Cr -42.27L -16.45L -2.07Cr -15.8L -15.46L -6.65Cr |
| Net Debt | 27.72L 19.32L 17.23L 16.06L 14.61L 27.52L 19Cr 1.94Cr 75.48L 9.5Cr 72.52L 70.96L 31Cr | 8L 6L 5L 5L 4L 8L 5.46Cr 56.9L 22.14L 2.78Cr 21.27L 20.81L 8.95Cr |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | A$0.0100 | 0.00% | 5,000 |
| 05/26/05 | A$0.0100 | 0.00% | 14,01,470 |
| 02/26/02 | A$0.0100 | 0.00% | 13,92,258 |
| 01/26/01 | A$0.0100 | +11.11% | 10,907 |
| 30/26/30 | A$0.009000 | -5.26% | 10,83,094 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ACR Stock
Select your edition
All financial news and data tailored to specific country editions

















